Edition:
United States

Accelerate Diagnostics Inc (AXDX.OQ)

AXDX.OQ on NASDAQ Stock Exchange Capital Market

22.00USD
2:26pm EDT
Change (% chg)

$-0.95 (-4.14%)
Prev Close
$22.95
Open
$22.90
Day's High
$22.90
Day's Low
$21.80
Volume
16,643
Avg. Vol
53,464
52-wk High
$30.30
52-wk Low
$16.85

Chart for

About

Accelerate Diagnostics, Inc. is an in vitro diagnostics company engaged in providing solutions that develop patient outcomes through the diagnosis of serious infections. The Company's in vitro diagnostic platform, the Accelerate Pheno system utilizes genotypic technology to identify (ID), infectious pathogens and phenotypic... (more)

Overall

Beta: 2.18
Market Cap(Mil.): $1,209.21
Shares Outstanding(Mil.): 53.98
Dividend: --
Yield (%): --

Financials

  AXDX.OQ Industry Sector
P/E (TTM): -- 45.08 30.58
EPS (TTM): -1.41 -- --
ROI: -43.93 7.84 12.84
ROE: -65.34 11.57 15.02

BRIEF-Accelerate Diagnostics Q1 Loss Per Share $0.37

* Q1 EARNINGS PER SHARE VIEW $-0.32 -- THOMSON REUTERS I/B/E/S Source text for Eikon: Further company coverage:

May 09 2018

BRIEF-Accelerate Diagnostics announces pricing of $150 mln notes offering

* ACCELERATE DIAGNOSTICS, INC. ANNOUNCES PRICING OF $150 MILLION CONVERTIBLE NOTES OFFERING

Mar 23 2018

BRIEF-Accelerate Diagnostics Announces $150 Mln Convertible Notes Offering

* ACCELERATE DIAGNOSTICS INC. ANNOUNCES $150 MILLION CONVERTIBLE NOTES OFFERING

Mar 22 2018

BRIEF-Accelerate Diagnostics Qtrly Net Loss $0.27 Per Share

* ACCELERATE DIAGNOSTICS REPORTS Q4 AND FULL-YEAR FINANCIAL RESULTS FOR 2017

Feb 15 2018

Earnings vs. Estimates